Artivila Biopharma
PrivateLast Round
Series A
Jun 25, 2026
Total Funding Raised
$35.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Artivila Biopharma operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series A round in June 2026.
Artivila Biopharma is a biotechnology company that develops innovative drugs for autoimmune diseases, neurodegenerative diseases, and oncology using an AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artivila Biopharma Comparables
Compare Artivila Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 83% | |
| Terray Therapeutics | 79% | |
| Genesis Molecular AI | 79% |
For institutional investors. Book with your work email.
Artivila Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2026 | ||||
| VC Round | Mar 31, 2022 | ||||
| Seed | Mar 30, 2021 | ||||
| Angel | Nov 1, 2019 |
For institutional investors. Book with your work email.
Artivila Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Seed |
| Hike Capital | VC Round |
| Jiangsu Honghui Equity Investment Management | Seed |
| 幂方资本 | Seed |
| Bopu Asset Management | Angel |
| Anlong Fund | Angel |
| Yijing Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Job postings increased from 0 to 2 roles, representing 40% of headcount.
- Jun 25, 2026
$13M round led by Green Pine Capital Partners
For institutional investors. Book with your work email.
Artivila Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Artivila Biopharma's valuation, stock price, and market status.
Is Artivila Biopharma a public or private company?
Artivila Biopharma is a private company.
What is the current stock price of Artivila Biopharma?
Artivila Biopharma is a private company, so its shares have no public market price. Caplight tracks Artivila Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Artivila Biopharma worth (valuation)?
Valuation information for Artivila Biopharma is not publicly available.
Can I buy Artivila Biopharma stock?
Artivila Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Artivila Biopharma's last funding round?
Artivila Biopharma's most recent funding round was Series A on June 25, 2026.
Who are the main investors in Artivila Biopharma?
Key investors in Artivila Biopharma include HighLight Capital, Jiangsu Honghui Equity Investment Management, 松禾资本 (Green Pine Capital Partners).
Will Artivila Biopharma IPO soon?
No public IPO plans have been announced for Artivila Biopharma.
How can I track Artivila Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Artivila Biopharma's shares on secondary markets.